Tuesday, May 2, 2017

Economic Factors Affecting the Seasonal Influenza Vaccination Market in East Europe: Ken Research

In 2009, a recommendation of the European Union (EU) health Council was issued in order to increase the vaccination of risk groups and healthcare workers in addition to further technical and scientific expertise. The essentiality of this guidance was to provide the EU Member States with relevant information regarding the decision-making process on routine vaccination of healthy children, adults and pregnant women with seasonal influenza vaccine, giving a flourishing push to the market of seasonal influenza vaccination.
Collectively referring to the Eastern European countries of Romania, Hungary, Slovenia and Slovakia, wherein the seasonal vaccination is recommended for children, the latter for ages>6 months to <13 years and the former for ages>6 months to <3 years, with no reimbursement of vaccine costs. Within these specific countries, the vaccination policy of Slovenia differs from the rest by mandating the childhood vaccination across nine areas to be necessary with excluding the exceptions based on religious belief along with the implementation of fines for those who fail to comply, thus giving a further impetus to the growth of the market. The remaining countries followed the recommendations of those aged >60 in Hungary and >65 in Romania. According to a recent article published by ken research, it can be conferred that in terms of children vaccination, Romania & Hungary together accounts for more than 40 percent market share in 2016 whereas, in adult vaccination segments, these two will share more than 80 percent market share by 2022. Furthermore, only the country of Romania is provided with the public funding for the vaccine. Therefore, it can be accomplished that Romania is having the highest seasonal influenza vaccine market share in East Europe Countries, as mentioned in the Ken Research report.
East Europe Influenza Vaccine Market Research Report
Ken Research says, in order for the systematic review of the search strings for influenza, geographical scope, burden of influenza, vaccine safety, vaccine effectiveness, and cost effectiveness, PubMed was used as the core database along with Embase for the influenza burden in pregnant women. For the fulfillment of the purpose, these search strings were combined with search strings for population, i.e. children, adults, pregnant women and contact of young children. The European Union (EU) recommendation for the influenza virus strains has been issued by the European Medicines Agency that should be included in the vaccines for the prevention of seasonal influenza from the autumn of 2017.
According to the report “Seasonal Influenza Vaccination Market in Hungary, Romania, Slovakia Slovenia (East Europe) By (Infant & Adult) Forecast”, the effective growth of the seasonal influenza vaccination industry can be attributed to many factors, such as the increasing burden of the seasonal influenza, technological and scientific advancements with new vaccines uncovering the surface, increasing health awareness among consumers, desire to live healthy lives with the increasing expenditure ability, etc. resulting in the increased involvement of the younger patients along with their families undergoing vaccinations. Their market is also well assisted by the recent biotechnological developments. The impetus growth can also be attributed to the continuous rise in the occurrence of a range of seasonal influenza requiring vaccination aided by the various governmental policies launching targeted vaccination programs. However, vaccinating all children would lead to herd immunity thus reducing overall transmission of influenza. Also, the introduction of universal influenza vaccination of children affects the overall childhood vaccination schedule and hardly any European studies regarding the vaccine effectiveness have been identified in children along with no post-vaccine safety studies, further resulting in the constricted extension of the market.
Key topics covered in report
Influenza Vaccine Market Research Report
Influenza Vaccine Market in Hungary
Influenza Vaccine Market in Romania
Influenza Vaccine Market in Slovakia
Global Influenza Vaccine Industry
Influenza Vaccination Market in East Europe
East Europe Influenza Vaccination Market Size
East Europe Influenza Vaccination Market Outlook
East Europe Influenza Vaccination Market Players
For more coverage click on the link below:
Related Reports
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
Posted by at No comments:
Labels: , , , ,

Monday, May 1, 2017

China Deproteinized Calf Blood Extract Market, 2010-2019: Ken Research

As a drug improving energy metabolism, deproteinized calf blood extract has received wide attention due to its efficacy in nervous system. Currently, it is mainly used to treat brain disease, nervous system disease, vascular disease, ulcer, burn, radiation injury and eye disease.
Developed by Jaeger KH with membrane filtering technology, deproteinized calf blood extract is the deproteinized blood extract of new- born calf with a relative molecular mass of less than 6000 dalton. Since the 1960s, deproteinized calf blood extract has been marketed all over the world.
China Deproteinized Calf Blood Extract Market Research Report
Recently, nervous system drug has reported a stable growth. Among the TOP500 drugs in the seven big markets, nervous system drug reported a sales value of USD 43.286 billion with a year- on- year growth of 3% in 2013. Brain system drug, in particular, has undergone a downturn in global market. However, as people become increasingly aware of the pathogenesis and clinical pharmacology of neurologic diseases, the market of neurologic drug has grown fast in China. As a leading neurologic drug, deproteinized calf blood extract has reported a large sales in China. By the end of August 2015, there are 18 manufacturers of deproteinized calf blood extract and deproteinized calf blood extract injection, 3 manufactures of deproteinized calf blood extract ophthalmic gel and 1 manufacturer of deproteinized calf blood extract capsule.
According to this market survey, the sales value of deproteinized calf blood extract in sample hospitals reached about CNY 1.2 billion and CAGR during the period of 2005- 2014 surpassed 30%. Jinzhou Ahon Pharmaceutical Co., Ltd, Heilongjiang Jiangshi Pharmaceutical Co., Ltd, Harbin Sanctity Pharmaceutical Co., Ltd, Jilin Connell Pharmaceutical Co., Ltd and Wuhan Humanwell Pharmaceutical Co., Ltd occupy the market, among which Jinzhou Ahon Pharmaceutical Co., Ltd had the largest market share of about 71% for sales value in 2014.
The market size of deproteinized calf blood extract in China is expected to keep growing in next few years.
Readers can get the following information through this report:
Market size of deproteinized calf blood extract in China
Competitive landscape of deproteinized calf blood extracts market in China
Price of deproteinized calf blood extract made by different enterprises in China
Market outlook of deproteinized calf blood extract in China
The author suggests the following groups of people purchase this report:
Drug makers
Investors/research institutions interested in Chinese medicine market
Key topics covered in report
China Deproteinized Calf Blood Extract Market
China Deproteinized Calf Blood Extract Market Size
China Deproteinized Calf Blood Extract Market Sales
China Deproteinized Calf Blood Extract Market Share
China Deproteinized Calf Blood Extract Market Players
China Deproteinized Calf Blood Extract Market Outlook
China Deproteinized Calf Blood Extract Market Forecast
China Deproteinized Calf Blood Extract Market Analysis
China Deproteinized Calf Blood Extract Market Research Report
For More Coverage Click On the Link Below:
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
Posted by at No comments:
Labels: , ,

China Latanoprost Market, 2010-2019: Ken Research

Glaucoma is an irreversible eye disorder which can lead to blindness. According to the statistics published by WHO in 2005, glaucoma is the second- leading cause of blindness after cataract. The number of glaucoma patients around the world is 70 million and will reach 80 million by 2020. And 50% of blindness cases in the world are caused by glaucoma. According to epidemiological studies of eye disease, by Feb. 2015, 2.3% of people aged above 40 suffer from glaucoma, among which about 30% may become blind.
China Latanoprost Market Research Report
Developed by Pharmacia & Upjohn in 1995, latanoprost is a selective prostaglandin receptor agonist which effectively reduces intraocular pressure. As the first pressure- lowering prostaglandin approved by FDA, latanoprost (under the trade name of Xalatan) entered China in 1999. In 2004, latanoprost eye drop developed by Lunan Better Pharmaceutical Co., Ltd was approved to be marketed, followed by products of Merro Pharmaceutical Co., Ltd, Hengrui Pharmaceutical and China Resources Zizhu Pharmaceutical Co., Ltd. Latanoprost has already become the first- line drug for the treatment of glaucoma.
Latanoprost developed fast after entering China, with sales value rising from CNY 25.27 million in 2013 to CNY 26.40 million in 2014 with a year-on-year growth of 4.47% and CAGR during the period of 2010- 2014 reaching 24.02%. With ageing population, the incidence of glaucoma continues to increase. Unlike cataract which can be treated with surgery, glaucoma provides a large market for conservative and postoperative medication. Therefore, latanoprost enjoys a vast demand in China.
Pfizer Manufacturing Belgium NV, Pharmacia & Upjohn (Belgium), Lunan Better Pharmaceutical Co., Ltd, China Resources Zizhu Pharmaceutical Co., Ltd and Pharmacia & Upjohn (Sweden) occupy the majority of the market share, among which Pfizer Manufacturing Belgium NV had the largest market share of about 43.1% for sales value in 2014. However, its market share was even larger i.e. 44.3% in 2013. Meanwhile, the market share of Pharmacia & Upjohn also decreased from 30.8% in 2013 to 29.5% in 2014. On the contrary, local manufacturers like Lunan Better Pharmaceutical Co., Ltd and China Resources Zizhu Pharmaceutical Co., Ltd both reported an increased market share (a 1.5% increase from 13.7% to 15.2% achieved by Lunan Better) in 2014 and will gain a larger share as biological technology develops further and they come to know more about domestic drugs.
Readers can get at least the following information from this report:
Market size of latanoprost in China
Major manufacturers of latanoprost in Chinese market
Retail price of latanoprost in China
Market outlook of latanoprost in China
The author suggests the following groups of people purchase this report:
Manufacturers of ophthalmic drugs
Investors/research institutions interested in Chinese medicine market
Key topics covered in report
China Latanoprost Market Size
China Latanoprost Market Sales
China Latanoprost Market Share
China Latanoprost Market Players
China Latanoprost Market Outlook
China Latanoprost Market Forecast
China Latanoprost market Anlaysis
China Latanoprost Market Research Report
For More Coverage Click On the Link Below:
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
Posted by at No comments:
Labels: , , ,

China Loversol Market, 2010-2019: Ken Research

As a non- ionic contrast medium, ioversol featuring low toxicity and few effects is mainly used to enhance the contrast of blood vessels in medical imaging. Containing iodine, ioversol works based on x- ray attenuation.
Contrast medium is commonly used to enhance the visibility of blood vessels and body cavity. And its application area has expanded from X- ray/CT imaging to ultrasound scattering and magnetic resonance imaging. In recent years, contrast agent market in China has maintained a growth of about 20%. Ioersol, in particular, has reported a growth of 60%. Currently, ioersol is used in many hospitals due to its cheap price and good quality.
China Loversol Market Research Report
Ioversol enjoys a vast demand with sales value of ioversol rising from less than CNY 30 million in 2005 to over CNY 200 million in 2014 and CAGR during this period reaching 27%. Mallinckrodt Medical Inc.(Canada), Mallinckrodt Medical Inc.(USA) and Jiangsu Hengrui Medicine Co., Ltd mainly occupy the market, among which Jiangsu Hengrui Medicine Co., Ltd had the largest market share of over 80% for sales value in 2014.
Readers can get the following information through this report:
Market size of ioversol in China
Competitive landscape of ioversol market in China
Price of ioversol made by different enterprises in China
Market outlook of ioversol in China
The author suggests the following groups of people purchase this report:
Drug makers
Investors/research institutions interested in Chinese medicine market
Key topics covered in report
China Ioversol Market Sales
China Ioversol Market Share
China Ioversol Market Players
China Ioversol Market Outlook
China Ioversol Market Size
China Ioversol Market Forecast
China Ioversol Market Research Report
China Ioversol market Anlaysis
For More Coverage Click On the Link Below:
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249
Posted by at No comments:
Labels: , , , , ,

Money Laundering Practices And Impact On Economy- Ken Research

Research report on “The Impact of Money Laundering on Customer Due Diligence” highlights, money laundering is the process by which people disguise the proceeds from criminal conduct by making them appear as proceeds from legitimate source. In India this conversion of black money into white money is known as Hawala mechanism. Money laundering generally involves three stages:
  • Placement: It involves depositing the illegal cash into the financial system.
  • Layering: This stage involves hiding the origin of funds by moving them through a series of financial transactions so that it becomes difficult to trace or detect.
  • Integration: This stage involves placing the illegal money into the economy through the banking system or legitimate source.


Customer due diligence is the analysis of the customers in context of legal issues like anti money laundering and also regulatory compliance. The important regulatory measures that drive CDD are The 4th AML Directive and Financial Action Task Force (FATF) Recommendations and Membership. The FATF is an inter-governmental body established in 1989 by the Ministers of its Member jurisdictions. The aim of the FATF is to set standards and to promote effective implementation of legal, regulatory and operational measures for keeping a check on money laundering, terrorist financing and the financing of proliferation and other related threats to the integrity of the international financial system.
Ken research has announced new research “The Impact of Money Laundering on Customer Due Diligence” on the impact of money laundering on customer due diligence which talks about the 4th money laundering directive which was passed by EU. The report gives the detailed analysis of the key operational and technological trends and challenges that institutions face due to the rapid rise in money laundering activity and frequent regulatory upgrades. Customer due diligence (CDD) also known as Know Your Customer (KYC) is central to an effective anti-money laundering and counter-terrorism financing (AML/CTF) regime. It is important to identify and verify each customer so as to determine the money laundering risk posed by the customer and also to determine whether to build the business relationship or not. According to the 4th money laundering directive simplified Customer Due Diligence will no longer be applicable in most circumstances. All transactions/clients require a degree of risk assessment to demonstrate that it presents a lower degree of risk and requires sufficient ongoing monitoring. There will be no blanket exemption from CDD. Transactions where enhanced due diligence (higher risk) will be required include those involving asset holding vehicles and cash-intensive businesses, those where unusual or apparently unnecessarily complex ownership structures are in place. Thus, strict rules are placed to avoid illegal activities.
Historically AML models relied on qualitative methods like expert judgment. However today, these models are integrated with sophisticated scoring algorithms and have other quantitatively derived components, such as segments and thresholds. These techniques have helped the AML industry to grow and provide accurate results. AML models include transaction monitoring software vendor products, large homegrown transaction monitoring systems, customer risk rating models and alert risk scoring models. These methods help in effective customer due diligence.
Despite all these models and methods of doing effective customer due diligence, it would be a challenging task for the nations to prevent money laundering. Risk of cyber threats and cybercrimes continue to rise. The rise of financial technology presents the challenge as the services of online money payment methods like bitcoin, paytm escalates the movement of funds become easier and quicker. As accessibility to global payments increases, the money laundering risk in the industry will similarly escalate and require institutions to implement heightened controls. Also, the markets are becoming more integrated and hence tracing the transactions becomes difficult. However, technology in this case will play an important role in managing money laundering and checking the customer’s background. Artificial intelligence and machine learning can support AML and financial crime compliance. As technology becomes more and more complex, one needs to understand not only the challenges presented by increased globalization, but also the opportunities to better understand and manage risk with enhanced solutions.
Topics Covered in The Report
  • Impact Of Money Laundering On Customer Due Diligence,
  • Global money laundering sector,
  • EU money laundering directive analysis,
  • Common Reporting Standards regulation,
  • IT Security Services Expenditures,
  • Global money laundering sector history,
  • Global anti money laundering market ,
  • Global anti money laundering market Research,
  • Global money laundering market Research,
  • Global money laundering market growth,
  • Global money laundering market trends,
  • Global money laundering market analysis ,
For further details click on the link below
https://www.kenresearch.com/banking-financial-services-and-insurance/financial-services/impact-money-laundering-customer-due-diligence/74567-93.html
Related Reports
2017 Top 5 Anti-money Laundering Software Manufacturers in North America, Europe, Asia-Pacific, South America, Middle East and Africa
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249
Posted by at 1 comment:
Labels: , , ,
Location: Europe

Sustainability in Tourism, Changing Trends: Ken Research

Sustainability in tourism is a positive phenomenon which lays emphasis on the growth of the local communities, culture, support the local people so as they can be the part of the industry and helps in contributing to it.
Market Research firm Ken Research, in its recently announced report states about the Sustainability in the Travel and Tourism Industry providing information about the key trends and opportunities. Travel and tourism industry works hand in hand so as to support the sustainability in tourism and make it beneficial for them. The basic idea of sustainable tourism is to pay back the demographics which help them to grow.
Global Travel and Tourism Industry
Report title “Changing Trends in Business Travel Booking in 2016-2017“describe that the need for the sustainable tourism arise because of with the rise in the tourism, there has been a significant impacts on natural resources, consumption pattern, social systems etc. therefore for surviving in long term, the need for sustainable management should be adopted by the travel and tourism industry. Many travel and tourism industries have already started contributing their bit in sustainable tourism by reducing cost, improving efficiency, and minimizing the carbon footprints.
Despite of the high establishment cost of sustainable tourism, it helps in reducing the operational cost and enhancing the workers’ productivity which will indirectly help in generating revenues for the travel and tourism companies.
The travel and tourism companies have especially came up with the ideas like the consumers will be charged 10% more if they want green lodging which helps in sustainable tourism.
The sustainable tourism gives rise to three tourism activities:
Voluntourism: It deals with teaching the local people about the travel transformation and giving them knowledge about various languages.
Ecotouism: The basic idea behind this tourism is that the tourist will travel more to the remote areas to enjoy the holistic side to nature.
Pro-poor tourism: This kind of tourism means where instead of going on a vacation then , the tourist visit in any of the poverty stricken areas where people are in a need to food , medicine and etc.
But what is the use of sustainable tourism and how it will be helping? The sustainable effect on travel and tourism cannot be underestimated. The positive power of both the money and utilisation of manpower to bear some social issues. Huge amount have been spent on sustainable tourism. It acts as a valuable economic tool for the travel and tourism industry as it will increase the revenues for it and also helps in maintain social responsibility.
Key topics covered in report
Global Travel and Tourism Industry
Global Tourism Market Competition
Travel and Tourism Industry Future Outlook
Global Hotel Sector
Global Travel and Tourism Market Analysis
Global Travel and Tourism Companies
Business Travel Industry Research
For More Coverage Click On the Link Below:
Related Reports
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
Posted by at No comments:
Labels: , , , ,
Subscribe to: Posts (Atom)